- Research works
- 20 ▲ 7% vs 2018-21
- Citations
- 862 42.1 per fractional work
- Top-10% rate
- 2.1% all institutions 10.0%
- Open access
- 16% world 40%
- International
- 12% world 18%
Not ranked overall: BioCer Entwicklungs (Germany) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does BioCer Entwicklungs (Germany) work in?
In all years, 45% of research at BioCer Entwicklungs (Germany) is in Health Sciences, 41% in Physical Sciences. Its largest fields are Medicine (34%), Engineering (32%), Biochemistry, Genetics and Molecular Biology (14%). It does 1.6× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 3 domains and 10 fields, with their numbers
- Health Sciences944.8%
- Medicine734.4%
- Dentistry29.9%
- Veterinary00.5%
- Physical Sciences841.1%
- Engineering732.0%
- Materials Science16.4%
- Chemistry01.6%
- Chemical Engineering00.8%
- Environmental Science00.3%
- Life Sciences314.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at BioCer Entwicklungs (Germany)?
Ranked on the quality score, Frank Heidenau lead among researchers whose main affiliation is BioCer Entwicklungs (Germany).
- 1
Frank Heidenau
Germany · #3,468,535 worldwide 551 citations · 21 works
Which keywords describe research at BioCer Entwicklungs (Germany)?
By fractional works in all years, weighted toward what it does more of than the world: Bone Regeneration, Tissue Engineering, Biomaterials, Hydroxyapatite, Scaffolds, Epidemiology, Clinical Practice Guidelines and Quality of Life.
- Model Predictive Control
- Dental Materials
- Wear Particles
- Total Hip Replacement
- Varicose Veins
- Quality of Life
- Scaffolds
- Biomaterials
- Tissue Engineering
- Bone Regeneration
- Epidemiology
- Hydroxyapatite
- Clinical Practice Guidelines
- Chronic Venous Insufficiency
- Revision Surgery
- Hip Arthroplasty
- Treatment
- Electric Vehicles
- Restorative Dentistry
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 19 words, with their numbers
- Bone Regeneration4▲ 183×2 topics
- Tissue Engineering4▲ 35×5 topics
- Epidemiology4▲ 4.2×9 topics
- Biomaterials3▲ 84×4 topics
- Hydroxyapatite3▲ 249×1 topic
- Scaffolds3▲ 249×1 topic
- Clinical Practice Guidelines3▲ 23×3 topics
- Quality of Life2▲ 8.8×3 topics
- Chronic Venous Insufficiency2▲ 466×1 topic
- Varicose Veins2▲ 466×1 topic
- Revision Surgery2▲ 68×2 topics
- Total Hip Replacement2▲ 68×2 topics
- Hip Arthroplasty2▲ 114×1 topic
- Wear Particles2▲ 114×1 topic
- Treatment1▲ 4.0×4 topics
- Dental Materials1▲ 101×1 topic
- Electric Vehicles1▲ 30×2 topics
- Model Predictive Control1▲ 21×2 topics
- Restorative Dentistry1▲ 101×1 topic
Which research topics does BioCer Entwicklungs (Germany) publish most on?
By volume in 2022-now: Infective Endocarditis Diagnosis and Management, Infectious Aortic and Vascular Conditions, Orthopedic Infections and Treatments and Conducting polymers and applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Infective Endocarditis Diagnosis and Management Epidemiology 0 works
- 2 Infectious Aortic and Vascular Conditions Surgery 0 works
- 3 Orthopedic Infections and Treatments Surgery 0 works
- 4 Conducting polymers and applications Polymers and Plastics 0 works
- 5 Advanced Battery Materials and Technologies Electrical and Electronic Engineering 0 works
- 6 Advancements in Battery Materials Electrical and Electronic Engineering 0 works
- 7 Acute Myeloid Leukemia Research Hematology 0 works
- 8 Protein Degradation and Inhibitors Molecular Biology 0 works
- 9 Chronic Myeloid Leukemia Treatments Hematology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has BioCer Entwicklungs (Germany)'s research output changed?
Output in 2022-2025 was 7% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is BioCer Entwicklungs (Germany) as a percentage of every work published that year, 0.0000069% in 2023.
Fractional works of BioCer Entwicklungs (Germany) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Bayreuth
- University of Bayreuth
- Deutsche Rentenversicherung Bund
- Institute for Innovative Process Engineering
- Tennet (Germany)
- Labor Pachmann
- Future Carbon (Germany)
- Medi (Germany)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about BioCer Entwicklungs (Germany). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.